Santosh Hegde too slams Amnesty International, justifies sedition charge

Mangaluru, Feb 28: BJP Corporator in Mangaluru's ward number 46 (Cantonment), Divakar, has been elected as the Mayor of the city on Friday. While Janaki aka Vedavathi, Corporator of ward number 9 (Kulai), has been elected as the Deputy Mayor.

Divakar secured 46 votes including that of MLAs D Vedavyasa Kamath and Dr Y Bharath Shetty.

Regional Commissioner V Yashwanth conducted the election at the Council Hall of Mangaluru City Corporation (MCC).

Two nominations were filed for the post of Mayor. Congress had fielded Keshav, representing ward 37 (Maroli) for the post of Mayor. Keshav secured 15 votes including that of MLC Ivan D'Souza.

Congress had fielded Zeenath Samshuddin of ward number 44 (Bunder) for the post of Deputy Mayor and secured 17 votes.

Two Social Democratic Party of India (SDPI) corporators remained neutral for the post of Mayor while they supported the candidature of Zeenath Samshuddin of Congress for the Deputy Mayor post. Janaki aka Vedavathi of the BJP secured 46 votes.

The BJP had swept the elections to the 60-member council held on November 12 by winning 44 wards, while the Congress won 14 wards. Social Democratic Party of India won two seats.

Election to the post of Mayor and Deputy Mayor was conducted as per the reservation roaster for the 21st term dated September 3, 2018. Accordingly, the Mayor's post was reserved for candidate from BCM ‘A’ category while that of Deputy Mayor for woman general.

Mangaluru, Apr 3: The Dakshina Kannada district administration’s decision to ban use of private vehicles, excluding permitted categories, from Friday for effective implementation of lockdown, began showing results since morning itself.

Mangaluru City Traffic Police and Dakshina Kannada district police erected several pickets at vantage places on arterial roads to check those moving without a valid reason. Several two-wheelers were seized during the checking while a few car drivers were let off with a strict warning.

Assistant Commissioner of Police (Traffic), M Manjunatha Shetty, who was supervising a picket at Hampankatta, said that movement of private vehicles has drastically reduced in the city.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.